Menu Close

How several consumers still suffer from ‘long COVID-19’: CDC

*The US Centers for Disease Control and Prevention found that COVID-19 survivors are twice as likely to develop pulmonary embolism or respiratory conditions

Isola Moses | ConsumerConnect

As the United States (US) Centers for Disease Control and Prevention (CDC) identifies most common symptoms of long COVID, a new study has suggested that not everyone who recovers from the Coronavirus (COVID-19) pandemic gets a clean bill of health.

The American health regulatory agency found that COVID-19 survivors are twice as likely to develop pulmonary embolism or respiratory conditions.

Pfizer CEO Albert Bourla

The study findings indicated that one in five COVID-19 patients who recover and are between the ages of 18 and 64 have at least one lingering condition that could be a result of their COVID-19 infection – a condition known as long COVID.

For people aged 65 and older, the odds of lingering symptoms are one in four, said the regulator.

Aside from neurological issues, the CDC also identified cardiovascular conditions, kidney failure, respiratory conditions, musculoskeletal conditions, and blood clots as the most common lingering effects associated with long COVID.

Pfizer CEO predicts constant waves of the virus

In a related development, Pfizer Chief Executive Officer (CEO) Albert Bourla predicts that the world could experience “repeated waves” of the coronavirus.

It is suggested that if the current buildup in COVID-19 cases turns into another wave, it might be something to get used to.

In an interview with the Financial Times (FT), Bourla said weakening immunity from previous infections and vaccinations could lead to “constant waves” of COVID-19 variants and deaths, especially if people stop taking precautions.

“What worries me is the complacency.”

The Pfizer CEO stated that the public is growing tired of mitigation measures.

Kindly Share This Story

 

Kindly share this story